Ad
related to: data integrity in pharmaceutical industry
Search results
Olema Pharmaceuticals Inc (NASDAQ:OLMA): Buy, Sell Or Hold At $10.86? – Marketing Sentinel
Marketing Sentinel· 6 days agoIn last trading session, Olema Pharmaceuticals Inc (NASDAQ:OLMA) saw 0.68 million shares changing hands with its beta currently measuring 2.09. Taking a look at company’s ...
Checking in on Vertex Pharmaceuticals, Inc.
Knox Daily· 5 days agoIn a filing, Vertex Pharmaceuticals, Inc. revealed its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company...The company we're about to show you is the ONLY small-cap ...
New report shows sustained growth for Washington's life science industry - Puget Sound Business...
The Business Journals· 18 hours agoA new economic impact report from industry group Life Science Washington takes stock of the state's...
Eagle Pharmaceuticals Inc (EGRX) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 4 days agoThe stock of Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has increased by 13.29 when compared to last closing price of 4.59.Despite this, the company has seen a gain of 4.00% ...
Potential Price Increase for Terns Pharmaceuticals Inc
Knox Daily· 5 days agoIn a filing, Terns Pharmaceuticals Inc revealed its 10% Owner Vivo Opportunity, LLC unloaded Company’s shares for reported $0.86 million...The company we're about to show ...
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoVertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So,...
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol...
Digital Journal· 4 days agoHenrik Klitgaard, Ph.D., a widely respected epilepsy industry expert and former Head of Epilepsy Research at UCB from 1994 to 2019, led the early development.... Moustafa, ...
Where Will Recursion Pharmaceuticals Be in 5 Years?
Motley Fool via Yahoo Finance· 2 days agoRecursion is already working with both Roche and Bayer, a pair of major European pharmaceutical businesses, and if those projects go well, over the next...
Adial Pharmaceuticals Inc (ADIL) Shares Decline Despite Market Challenges – News Heater
NewsHeater· 5 days agoAdial Pharmaceuticals Inc (NASDAQ: ADIL)’s stock price has gone decline by -21.81 in comparison to its previous close of 2.98, however, the company has experienced a 100.86% ...
Bluecrux & Pharmaceutical Innovator Forge Path Toward QC & Supply Chain Integration:...
The Daily Advance· 1 day agoORLANDO, Fla., April 18, 2024 /PRNewswire/ -- Bluecrux partnered with global biopharmaceutical leader AstraZeneca to drastically improve lab operations by implementing Binocs, Bluecrux's state of the art lab planning technology,
